|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
EBOOKCENTRAL_ocn739118473 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
110706s2011 njua ob 001 0 eng d |
010 |
|
|
|z 2010048282
|
040 |
|
|
|a DG1
|b eng
|e pn
|c DG1
|d CDX
|d E7B
|d N$T
|d OCLCQ
|d YDXCP
|d OCLCQ
|d MYG
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|d OCLCF
|d OCLCA
|d OCLCQ
|d NLGGC
|d TEFOD
|d DEBSZ
|d MHW
|d IDEBK
|d UKDOC
|d K6U
|d DEBBG
|d TEFOD
|d OCLCQ
|d EBLCP
|d OCLCQ
|d NKT
|d OCLCQ
|d D6H
|d AZK
|d DG1
|d COCUF
|d CHVBK
|d UAB
|d CNCGM
|d OCLCO
|d MOR
|d MERER
|d OCLCO
|d LIP
|d OCLCO
|d PIFAG
|d OCLCO
|d ZCU
|d OCLCO
|d OCLCQ
|d MERUC
|d OCLCO
|d OCLCQ
|d OCLCO
|d STF
|d OCLCO
|d OCLCA
|d U3W
|d OCLCO
|d OCLCQ
|d WRM
|d NRAMU
|d ICG
|d INT
|d VT2
|d AU@
|d OCLCO
|d OCLCQ
|d WYU
|d UWO
|d OCLCO
|d OCLCA
|d CUY
|d TKN
|d OCLCQ
|d OCLCO
|d OCLCA
|d OCLCQ
|d DKC
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d UKAHL
|d OCLCQ
|d OCLCA
|d VLY
|d OCLCO
|d VHC
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCL
|
016 |
7 |
|
|a 101547685
|2 DNLM
|
016 |
7 |
|
|a 015762162
|2 Uk
|
019 |
|
|
|a 746598433
|a 747412436
|a 747545802
|a 769950588
|a 811493909
|a 816850645
|a 832584725
|a 961547718
|a 962639106
|a 974576404
|a 974613745
|a 988457591
|a 991915259
|a 1018020256
|a 1037677328
|a 1038687391
|a 1041927239
|a 1045437606
|a 1053530887
|a 1055369103
|a 1065026979
|a 1081223217
|a 1162040515
|a 1290103058
|a 1303423852
|
020 |
|
|
|a 9781118023648
|q (electronic bk.)
|
020 |
|
|
|a 1118023641
|q (electronic bk.)
|
020 |
|
|
|a 9781118023624
|q (electronic bk.)
|
020 |
|
|
|a 1118023625
|q (electronic bk.)
|
020 |
|
|
|a 9781118023631
|q (electronic bk.)
|
020 |
|
|
|a 1118023633
|q (electronic bk.)
|
020 |
|
|
|z 9780470256374
|q (Cloth)
|
020 |
|
|
|z 0470256370
|q (Cloth)
|
020 |
|
|
|a 1283175657
|
020 |
|
|
|a 9781283175654
|
020 |
|
|
|a 9786613175656
|
020 |
|
|
|a 661317565X
|
024 |
8 |
|
|a 9786613175656
|
029 |
1 |
|
|a AU@
|b 000047774163
|
029 |
1 |
|
|a AU@
|b 000053280043
|
029 |
1 |
|
|a AU@
|b 000060546876
|
029 |
1 |
|
|a CHNEW
|b 000937934
|
029 |
1 |
|
|a CHVBK
|b 480182418
|
029 |
1 |
|
|a DEBBG
|b BV041911508
|
029 |
1 |
|
|a DEBBG
|b BV043393274
|
029 |
1 |
|
|a DEBBG
|b BV044154535
|
029 |
1 |
|
|a DEBSZ
|b 430992041
|
029 |
1 |
|
|a NLGGC
|b 337107459
|
035 |
|
|
|a (OCoLC)739118473
|z (OCoLC)746598433
|z (OCoLC)747412436
|z (OCoLC)747545802
|z (OCoLC)769950588
|z (OCoLC)811493909
|z (OCoLC)816850645
|z (OCoLC)832584725
|z (OCoLC)961547718
|z (OCoLC)962639106
|z (OCoLC)974576404
|z (OCoLC)974613745
|z (OCoLC)988457591
|z (OCoLC)991915259
|z (OCoLC)1018020256
|z (OCoLC)1037677328
|z (OCoLC)1038687391
|z (OCoLC)1041927239
|z (OCoLC)1045437606
|z (OCoLC)1053530887
|z (OCoLC)1055369103
|z (OCoLC)1065026979
|z (OCoLC)1081223217
|z (OCoLC)1162040515
|z (OCoLC)1290103058
|z (OCoLC)1303423852
|
037 |
|
|
|a 10.1002/9781118023648
|b Wiley InterScience
|n http://www3.interscience.wiley.com
|
037 |
|
|
|a E7E4375E-C1F9-4065-A07F-245F67847567
|b OverDrive, Inc.
|n http://www.overdrive.com
|
050 |
|
4 |
|a QR189
|b .D48 2011
|
060 |
|
4 |
|a 2011 J-967
|
060 |
|
4 |
|a QW 805
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615/.372
|2 22
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Development of Vaccines :
|b From Discovery to Clinical Testing /
|c edited by Manmohan Singh, Indresh K. Srivasta.
|
260 |
|
|
|a Hoboken, N.J. :
|b John Wiley & Sons,
|c ©2011.
|
300 |
|
|
|a 1 online resource (xiii, 454 pages) :
|b illustrations (some color)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a data file
|2 rda
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
0 |
|t Microbial vaccines design : the reverse vaccinology approach /
|r Roberto Rosini, Michele A. Barocchi, Rino Rappuoli --
|t Design and development of recombinant vaccines with viral properties /
|r Gerd Lipowsky, Martin F. Bachmann --
|t Tools for vaccine design : prediction and validation of highly immunogenic and conserved class II epitopes, and development of epitope-driven vaccines /
|r Anne S. De Groot [and others] --
|t Virus like-particle vaccines advantages and challenges /
|r Ted M. Ross [and others] --
|t Design platforms of nanocapsules for human therapeutics or vaccines /
|r Masaaki Kawano [and others] --
|t Designing immunogens for vaccine development in reference to HIV /
|r Aemro Kassa [and others].
|
505 |
8 |
0 |
|t Expression and purification of recombinant proteins for vaccine applications /
|r Carlo Zambonelli, Deeann Martinez-Guzmann, and Indresh K. Srivastava --
|t DNA vaccines for infectious diesase /
|r Samuel Stepenson, Manmohan Singh, Indresh K. Srivastava --
|t Developing stable cell lines for the production of vaccine antigens /
|r Xiaotian Zhong [and others] --
|t Spectroscopy of vaccines /
|r C. Russell Middaugh, Sangeeta B. Joshi --
|t Biophysical characterization of protein antigens within vaccine formulations /
|r Padima Malyala, Derek O'Hagan, Manmohan Singh --
|t Structural characteristics predict the stability of HIV /
|r Zohar Biron [and others] --
|t Selection of optimal adjuvants and product factors that affect vaccine immunogenicity /
|r Wei Wang, Manmohan Singh --
|t Lyophilization and stabilization of vaccines /
|r James Chesko [and others] --
|t Effect of buffers and stabilizers on vaccine stability and efficacy /
|r Shireesh P. Apte, Sydney Ugwu --
|t Selection of final product containers /
|r Luis Baez, Adrian Distler --
|t From the lab to the clinic : filing a phase I IND for an investigational vaccine /
|r Kenneth G. Surowitz.
|
588 |
0 |
|
|a Print version record.
|
520 |
|
|
|a Development of Vaccines: From Discovery to Clinical Testing outlines the critical steps, and analytical tools and techniques, needed to take a vaccine from discovery through a successful clinical trial. Contributions from leading experts in the critical areas of vaccine expression, purification, formulation, pre-clinical testing and regulatory submissions make this book an authoritative collection of issues, challenges and solutions for progressing a biologic drug formulation from its early stage of discovery into its final clinical testing. A section with details and real-life experien.
|
546 |
|
|
|a English.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Vaccines.
|
650 |
|
0 |
|a Drug development.
|
650 |
|
0 |
|a Drug stability.
|
650 |
1 |
2 |
|a Vaccines
|x pharmacology
|
650 |
2 |
2 |
|a Drug Discovery
|x methods
|
650 |
2 |
2 |
|a Drug Stability
|
650 |
|
2 |
|a Vaccines
|
650 |
|
6 |
|a Vaccins.
|
650 |
|
6 |
|a Médicaments
|x Développement.
|
650 |
|
6 |
|a Médicaments
|x Stabilité.
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Drug development
|2 fast
|
650 |
|
7 |
|a Drug stability
|2 fast
|
650 |
|
7 |
|a Vaccines
|2 fast
|
700 |
0 |
|
|a Manmohan Singh,
|d 1964 November 8-
|
700 |
1 |
|
|a Srivasta, Indresh K.
|
758 |
|
|
|i has work:
|a Development of Vaccines (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGcQpjwX6HydDHHHtTw9Qm
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|t Development of vaccines.
|d Hoboken, N.J. : John Wiley & Sons, ©2011
|z 9780470256374
|w (DLC) 2010048282
|w (OCoLC)682072290
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=697480
|z Texto completo
|
938 |
|
|
|a 123Library
|b 123L
|n 18341
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH16073069
|
938 |
|
|
|a Coutts Information Services
|b COUT
|n 18234392
|c 90.50 GBP
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL4030504
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10484637
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 382067
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n 317565
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 6628106
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 3537289
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 3588131
|
994 |
|
|
|a 92
|b IZTAP
|